Source: https://www.merchantgould.com/Professionals/Mary-R-Bram
Timestamp: 2019-04-20 21:08:13+00:00

Document:
Food Law 201: Intellectual Property and Patents, Grocery Manufacturers Association (GMA) Science Forum, Washington, DC (April 18, 2016). Presenters: Matthew L. Fedowitz and Mary R. Bram.
Ambush Marketing: Coming Soon to a Stadium Near You, Association of Corporate Counsel (January 22, 2013). Authors: Dickerson M. Downing, Mary R. Bram, Crowell & Moring and Rodrigo Azevedo, Silveiro Advogados.
New gTLDs: After the Reveal Day, The Bar Association of the District of Columbia: Patent, Trademark, & Copyright Section, Washington, DC (December 5, 2012). Presenters: Michael H. Jacobs, Elisa Cooper, Mary R. Bram, and Ronald L. Sigworth (Moderator).
New gTLDs: After the Reveal Day, Virginia State Bar Intellectual Property Section Fall CLE Weekend, Alexandria, Virginia (September 22, 2012). Presenters: Dickerson M. Downing, Michael H. Jacobs, and Mary R. Bram.
Alternative Dispute Resolution in Intellectual Property Cases, Federation of Industries of the State of Rio Grande do Sul (FIERGS), Porto Alegre, Brazil (July 13, 2012). Presenters: Dickerson M. Downing, Michael H. Jacobs, and Mary R. Bram.
I Seminário Brasil - EUA: A Propriedade Intelectual da Empresa na Internet, (Seminar U.S. - Brazil: A Company's Intellectual Property on the Internet), São Paulo, Brazil (July 11, 2012). Presenters: Dickerson M. Downing, Michael H. Jacobs, Rodrigo Azevedo, and Mary R. Bram.
Solving the Procedural Quagmire for Testing Reverse Payment Settlements, Minnesota Journal of Law, Science and Technology (Spring 2010). Authors: Richard McMillan, Jr., Mary Bram and M. Brinkley Tappan.
As a patent attorney in Merchant & Gould’s Washington, D.C. area office, Mary focuses her practice on the chemical and pharmaceutical arts. She has been registered to practice before the U.S. Patent and Trademark Office since 2006 and has significant experience with patent application drafting, patent procurement in the United States and worldwide, and appeals before the Patent Trial and Appeal Board.
Mary’s background in patent procurement makes her an effective advocate in post-grant patent proceedings at the U.S. Patent and Trademark Office and disputes in federal district court. She represents clients in inter partes review proceedings before the Patent Trial and Appeal Board. She also represents generic pharmaceutical companies in suits brought against them under the Hatch-Waxman Act.
Mary has experience with a wide range of chemical, chemical engineering, and pharmaceutical technologies, including oil and natural gas processing, petroleum chemistry, polymers, semiconductors, nuclear energy, coatings, alloys, building materials, nanomaterials, small molecules, pharmaceutical formulations, and drug delivery.
Mary also assists in the preparation of freedom to operate, validity, and non-infringement opinions and intellectual property due diligence.
In addition to her patent practice, Mary has successfully represented both domestic and foreign clients in their applications for new generic top-level domains (gTLDs) before the Internet Corporation for Assigned Names and Numbers (ICANN).
Prior to law school, Mary was an intern at the U.S. Patent and Trademark Office in Technology Center 1600.
Boehringer Ingelheim Pharma GmbH & Co. KG, et al. v. Teva Pharmaceuticals USA, Inc. et al. (D. N.J.). Challenging patent on dabigatran.
Coalition for Affordable Drugs II LLC v. NPS Pharmaceuticals Inc. (Patent Trial and Appeal Board), IPR2015-00990. Obtained final written decision in favor of Coalition for Affordable Drugs II LLC invalidating claims 46-52 and 61-75 of U.S. Patent No. 7,056,886.
Coalition for Affordable Drugs II LLC v. NPS Pharmaceuticals Inc. (Patent Trial and Appeal Board), IPR2015-01093. Obtained final written decision in favor of Coalition for Affordable Drugs II LLC invalidating claims 1-27, 31-40, 44, and 45 of U.S. Patent No. 7,056,886.
Novartis Pharmaceuticals Corporation, et al. v. Breckenridge Pharmaceutical, Inc., et al. (D. Del.). Challenging patents on everolimus.
Bayer Intellectual Property GmbH, et al. v. Breckenridge Pharmaceutical, Inc., et al. (D. Del.). Challenging patents on rivaroxaban.
FlashPoint Technology, Inc. v. Aiptek, Inc., et al. (D. Del.). Represented Leica entities in patent infringement action involving camera technology.
Presstek, Inc. v. Eastman Kodak Company (D. Colo.). Represented Kodak in its counterclaims of trade secret misappropriation.
Food Law Workshop at GMA Science Forum in D.C.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.